日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Installing biosafety level 3 containment laboratories in low- and middle-income countries: challenges and prospects from Mali's experience

在低收入和中等收入国家建立生物安全3级实验室:来自马里的经验及其挑战与前景

Kouriba, B; Ouwe Missi Oukem-Boyer, O; Traoré, B; Touré, A; Raskine, L; Babin, F X

Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance

法国一组患有赖氨酸尿蛋白不耐受症的儿科患者的肾脏受累情况

Nicolas, C; Bednarek, N; Vuiblet, V; Boyer, O; Brassier, A; De Lonlay, P; Galmiche, L; Krug, P; Baudouin, V; Pichard, S; Schiff, M; Pietrement, C

Evolving perspectives on broad consent for genomics research and biobanking in Africa. Report of the Second H3Africa Ethics Consultation Meeting, 11 May 2015

非洲基因组学研究和生物样本库广泛知情同意观点的演变。第二次H3Africa伦理咨询会议报告,2015年5月11日

de Vries, J; Littler, K; Matimba, A; McCurdy, S; Ouwe Missi Oukem-Boyer, O; Seeley, J; Tindana, P

Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study

利妥昔单抗治疗类风湿性关节炎患者B细胞耗竭监测在预测临床复发中的作用:一项前瞻性观察研究

Trouvin, A-P; Jacquot, S; Grigioni, S; Curis, E; Dedreux, I; Roucheux, A; Boulard, H; Vittecoq, O; Le Loët, X; Boyer, O; Goëb, V

[Biological markers in acute bronchiolitis: Correlations with gravity and risk factors for asthma]

[急性毛细支气管炎的生物标志物:与病情严重程度和哮喘危险因素的相关性]

Legru, E; Lees, O; Bubenheim, M; Boyer, O; Marguet, C

T cell repertoire in patients with stable scleroderma

稳定期硬皮病患者的T细胞库

Tiev, K P; Abriol, J; Burland, M C; Antonelli, D; Klatzmann, D; Cabane, J; Boyer, O

Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

HIV感染患者接受高效抗逆转录病毒治疗后,血浆TNF-α水平和外周血单核细胞(PBMC)中IFN-γ mRNA水平降低,而PBMC中IL-2 mRNA水平升高

Brazille P, Dereuddre-Bosquet N, Leport C, Clayette P, Boyer O, Vildé J-L, Dormont D, Benveniste O